World News

Esperion Therapeutics is being taken private by ARCHIMED in a $1.1 billion deal

https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c

Shareholders will receive $3.16 per share in cash at closing — a 58% premium — plus contingent payments of up to $100 million

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button